5 Healthcare Stocks to Buy Today According to Steven Cohen’s Point72 Asset Management

In this piece we will take a look at the top five healthcare stocks to buy today according to Steven Cohen’s Point72 Asset Management. If you want to learn about Mr. Cohen, his firm and his other prominent healthcare stock picks, then head on over to 10 Healthcare Stocks to Buy Today According to Steven Cohen’s Point72 Asset Management.

5. Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Point72 Asset Management’s Holdings: $103.6 million

Percentage of Point72 Asset Management’s Portfolio: 0.41%

Number of Hedge Fund Holders: 38

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is a biopharmaceutical firm that develops drugs based on RNA technology that target a myriad of diseases. These include muscular dystrophy and other genetic diseases.

Point72 Asset Management owned 1.1 million Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares by the end of Q4 2021, a $103.6 million stake which represented 0.41% of its 13F investment portfolio. During the same time period, 38 out of the 924 13F-filing hedge funds tracked by Insider Monkey’s database also owned the company’s shares.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) earned $201 million in revenue and  lost $0.77 in non-GAAP EPS for its fiscal fourth quarter, a strong set of results that beat Wall Street estimates for both metrics. Despite this, Barclays reduced its price target on the company’s shares to $104 from $125 in March 2022, nonetheless stating that the company’s drugs are on a strong developmental trajectory. Barclays also kept an ‘Overweight’ rating on the shares.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT)’s largest investor in our database is Kurt Von Emster’s VenBio Select Advisor, which owns 3.1 million shares worth $281 million.